RavenQuest BioMed Inc.
RVVQF
$0.00
$0.000.00%
OTC PK
| 07/31/2019 | 04/30/2019 | 01/31/2019 | 10/31/2018 | 07/31/2018 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 570.00K | 970.10K | 727.10K | 276.00K | 1.05M |
| Total Receivables | 696.40K | 236.20K | 511.80K | 765.30K | 1.17M |
| Inventory | 570.00K | 228.00K | 363.90K | 59.50K | -- |
| Prepaid Expenses | 257.90K | 456.20K | 703.70K | 676.80K | 2.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.09M | 1.89M | 2.31M | 1.78M | 4.74M |
|
|
|||||
| Total Current Assets | 2.09M | 1.89M | 2.31M | 1.78M | 4.74M |
| Net Property, Plant & Equipment | 15.43M | 14.75M | 14.51M | 12.96M | 10.93M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 12.51M | 12.76M | 13.49M | 13.94M | 24.22M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.00K | 3.00K | 3.00K | 3.00K | 3.10K |
| Total Assets | 30.04M | 29.40M | 30.31M | 28.68M | 39.89M |
|
|
|||||
| Total Accounts Payable | 1.76M | 1.70M | 1.97M | 1.55M | 1.85M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 1.11M | 1.07M | 1.08M | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.42M | 1.40M | 1.78M | 17.00K | 13.60K |
| Total Other Current Liabilities | 1.42M | 1.40M | 1.78M | 17.00K | 13.60K |
| Total Current Liabilities | 4.28M | 4.18M | 4.83M | 1.56M | 1.86M |
|
|
|||||
| Total Current Liabilities | 4.28M | 4.18M | 4.83M | 1.56M | 1.86M |
| Long-Term Debt | 10.14M | 10.42M | 10.09M | 10.09M | 9.62M |
| Short-term Debt | 1.11M | 1.07M | 1.08M | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.42M | 14.60M | 14.91M | 11.65M | 11.48M |
|
|
|||||
| Common Stock & APIC | 44.15M | 41.08M | 39.72M | 39.52M | 33.45M |
| Retained Earnings | -34.68M | -31.59M | -29.85M | -27.42M | -10.15M |
| Treasury Stock & Other | 6.15M | 5.31M | 5.54M | 4.94M | 5.12M |
| Total Common Equity | 15.62M | 14.80M | 15.40M | 17.03M | 28.41M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.62M | 14.80M | 15.40M | 17.03M | 28.41M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.62M | 14.80M | 15.40M | 17.03M | 28.41M |
|
|
|||||